www.angiochem.com
Angiochem is a clinical-stage biotechnology company based in Montreal dedicated to creating and developing novel therapies that cross the Blood-Brain Barrier (BBB) to treat brain diseases.
AngioChem Secures US $3 Million in Financing from MMV Financial, Inc.